Most sold healthcare stocks in Q4 2022
See which Healthcare stocks institutional investors trimmed or exited the most in Q4 2022, measured as net reductions in reported share positions from Q3 2022 into Q4 2022. Notable reductions at the top of this list include TEVA PHARMACEUTICAL-SP ADR (TEVA), BOSTON SCIENTIFIC CORP (BSX), FATE THERAPEUTICS INC (FATE), AVANTOR INC (AVTR). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| TEVA | TEVA PHARMACEUTICAL-SP ADR | -11,829,533 | $195.02M | 1 | 1 | 3 | 1 | 5 |
| BSX | BOSTON SCIENTIFIC CORP | -6,567,150 | $456.42M | 1 | 3 | 2 | 0 | 7 |
| FATE | FATE THERAPEUTICS INC | -6,165,997 | $42.27M | 0 | 2 | 1 | 0 | 3 |
| AVTR | AVANTOR INC | -5,841,220 | $213.35M | 0 | 1 | 3 | 1 | 7 |
| NUVB | NUVATION BIO INC | -5,726,315 | $7.36M | 0 | 0 | 2 | 0 | 4 |
| MRK | MERCK & CO. INC. | -4,022,662 | $367.83M | 1 | 5 | 11 | 2 | 21 |
| WRBY | WARBY PARKER INC-CLASS A | -3,337,565 | $163.53M | 0 | 0 | 3 | 0 | 3 |
| VTYX | VENTYX BIOSCIENCES INC | -3,311,834 | $32.64M | 0 | 1 | 1 | 0 | 2 |
| EHC | ENCOMPASS HEALTH CORP | -3,278,143 | $7.33M | 0 | 0 | 3 | 1 | 3 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | -3,006,611 | $209.98M | 0 | 0 | 2 | 0 | 2 |
| TDOC | TELADOC HEALTH INC | -2,861,809 | $447.90M | 1 | 0 | 5 | 0 | 6 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | -2,699,157 | $2.85M | 0 | 2 | 1 | 0 | 5 |
| GILD | GILEAD SCIENCES INC | -2,560,324 | $4.28B | 1 | 2 | 10 | 0 | 13 |
| AZN | ASTRAZENECA PLC-SPONS ADR | -2,262,236 | $43.67M | 1 | 2 | 4 | 0 | 8 |
| ABT | ABBOTT LABORATORIES | -2,012,337 | $2.11B | 2 | 4 | 7 | 0 | 19 |
| BDX | BECTON DICKINSON AND CO | -1,952,837 | $1.99B | 1 | 3 | 8 | 2 | 15 |
| PFE | PFIZER INC | -1,903,070 | $829.35M | 0 | 6 | 11 | 1 | 18 |
| SENS | SENSEONICS HOLDINGS INC | -1,848,088 | $17.82K | 1 | 0 | 0 | 1 | 1 |
| WEAV | WEAVE COMMUNICATIONS INC | -1,781,663 | $24.01M | 0 | 0 | 1 | 0 | 1 |
| ZTS | ZOETIS INC | -1,591,620 | $1.13B | 0 | 4 | 7 | 0 | 12 |
| NEOG | NEOGEN CORP | -1,580,579 | $2.24M | 0 | 0 | 2 | 0 | 3 |
| BHC | BAUSCH HEALTH COS INC | -1,489,921 | $4.87M | 2 | 0 | 0 | 1 | 4 |
| EXAS | EXACT SCIENCES CORP | -1,489,435 | $794.03M | 1 | 1 | 3 | 0 | 5 |
| ELV | ELEVANCE HEALTH INC | -1,487,216 | $3.51B | 0 | 4 | 9 | 0 | 15 |
| MCK | MCKESSON CORP | -1,350,705 | $2.28B | 1 | 2 | 6 | 0 | 9 |
| QSI | QUANTUM-SI INC | -1,344,050 | $21.65M | 1 | 0 | 1 | 0 | 3 |
| SIGA | SIGA TECHNOLOGIES INC | -1,304,921 | -$16.52K | 0 | 0 | 1 | 0 | 1 |
| APLS | APELLIS PHARMACEUTICALS INC | -1,090,141 | -$77.57K | 0 | 0 | 1 | 1 | 1 |
| CNC | CENTENE CORP | -1,050,060 | $4.78M | 0 | 2 | 2 | 0 | 5 |
| EXEL | EXELIXIS INC | -1,029,777 | $961.07K | 1 | 1 | 1 | 0 | 3 |
| CPRX | CATALYST PHARMACEUTICALS INC | -995,000 | -$5.66K | 0 | 0 | 1 | 0 | 1 |
| HYPR | HYPERFINE INC | -982,500 | -$795 | 1 | 0 | 0 | 1 | 1 |
| AMLX | AMYLYX PHARMACEUTICALS INC | -957,630 | $171.09M | 1 | 0 | 1 | 0 | 2 |
| CERS | CERUS CORP | -915,391 | $57.84M | 0 | 1 | 1 | 0 | 2 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | -913,970 | $4.22M | 0 | 1 | 1 | 0 | 2 |
| ZOM | ZOMEDICA CORP | -889,500 | -$193 | 0 | 0 | 1 | 0 | 1 |
| ABCL | ABCELLERA BIOLOGICS INC | -858,400 | -$7.98K | 0 | 0 | 1 | 0 | 1 |
| INCY | INCYTE CORP | -796,226 | $1.63B | 1 | 1 | 4 | 0 | 6 |
| VCYT | VERACYTE INC | -781,122 | $196.81M | 0 | 0 | 1 | 0 | 1 |
| BLUE | BLUEBIRD BIO INC | -692,734 | $440.69K | 1 | 0 | 0 | 1 | 1 |
| SANA | SANA BIOTECHNOLOGY INC | -652,300 | -$4.25K | 0 | 0 | 1 | 0 | 1 |
| ME | 23ANDME HOLDING CO -CLASS A | -600,400 | $48.74K | 0 | 0 | 1 | 1 | 2 |
| DHR | DANAHER CORP | -593,429 | $2.12B | 4 | 5 | 5 | 0 | 18 |
| ZLAB | ZAI LAB LTD-ADR | -565,517 | $60.23M | 0 | 1 | 2 | 0 | 3 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | -565,380 | -$7.12K | 0 | 0 | 0 | 1 | 0 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | -557,095 | $2.28B | 1 | 2 | 6 | 0 | 9 |
| ACCD | ACCOLADE INC | -549,349 | $42.45M | 0 | 0 | 2 | 0 | 3 |
| CABA | CABALETTA BIO INC | -524,061 | $1.06K | 0 | 0 | 1 | 0 | 1 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | -515,043 | $763.56M | 1 | 2 | 7 | 0 | 12 |
| ALT | ALTIMMUNE INC | -490,200 | -$4.39K | 0 | 0 | 1 | 0 | 1 |
Frequently asked questions about Most sold healthcare stocks in Q4 2022
What are the most sold Healthcare stocks in Q4 2022?
The most sold healthcare stocks in Q4 2022 are those with the largest decrease in reported share counts across institutional investors compared to Q3 2022, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q4 2022?
Among filers in this sector, net reductions were largest in companies such as TEVA PHARMACEUTICAL-SP ADR (TEVA), BOSTON SCIENTIFIC CORP (BSX), FATE THERAPEUTICS INC (FATE), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q3 2022).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.